Berte, Nancy <br/><br/>
Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs.  [electronic resource] 

 -  Molecular cancer therapeutics  11 2016 
 - 2665-2678 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-16-0176  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Chromosome Aberrations--drug effects<br/>DNA Damage<br/>DNA Modification Methylases--metabolism<br/>DNA Repair<br/>DNA Repair Enzymes--metabolism<br/>DNA Replication--drug effects<br/>DNA-Binding Proteins--metabolism<br/>Disease Models, Animal<br/>Glioblastoma--drug therapy<br/>Homologous Recombination--drug effects<br/>Humans<br/>Lomustine--pharmacology<br/>MRE11 Homologue Protein<br/>Mice<br/>Rad51 Recombinase--metabolism<br/>Tumor Suppressor Proteins--metabolism<br/>Xenograft Model Antitumor Assays